Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 278,634 | 0 | 0 | N/A |
| TOTAL | $279,238 | $0 | $0 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 28 | N/A | N/A | N/A |
| TOTAL | $28 | $N/A | $N/A | $N/A |
| Total Assets | $279,266 | $0 | $0 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 8,837 | 0 | 0 | 0 |
| Accrued Expenses | 2,727 | 0 | 0 | N/A |
| Other current liabilities | 60 | 0 | 0 | N/A |
| TOTAL | $11,624 | $0 | $0 | $N/A |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $11,624 | $0 | $0 | $N/A |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 37,761 | N/A | N/A | N/A |
| Retained earnings | -42,808 | 0 | 0 | N/A |
| TOTAL | $267,642 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $279,266 | $0 | $0 | $0 |